Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human von Willebrand factor

EU orphan designation number: EU/3/10/814   
Active ingredient: Recombinant human von Willebrand factor
Indication: Treatment of von Willebrand disease
Sponsor: Baxter Innovations GmbH
Industriestraße 67, A-1221 Wien, Österreich

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/12/2010 Centralised Orphan - Designation EMA/OD/055/10 (2010)8599 of 26/11/2010